Literature DB >> 1377492

Ion channel formation by duramycin.

T R Sheth1, R M Henderson, S B Hladky, A W Cuthbert.   

Abstract

The formation of ion channels by the nonadecapeptide antibiotic duramycin was examined using black lipid membranes and using the patch-clamp technique. In black lipid membranes made from glyceryl monooleate or a phosphatidylcholine/phosphatidylethanolamine mixture, duramycin induced complex fluctuations in membrane conductance, some step-like and some which were incapable of being resolved into discrete conductance states. Both conductance and largest step size increased with time. A similar time-dependent increase in conductance was seen in patch-clamp experiments with HCA-7 Colony 29 human colonic epithelial cell. The channels displayed weak anion selectivity and the smaller channels formed in patches from epithelial cells showed weak inward-rectification. Channel formation by duramycin was achieved at lower concentrations when the black lipid membrane was made with phospholipid rather than with glyceryl monooleate. Lower concentrations were effective in generating conductances in epithelial cells than in bilayers. It is concluded that duramycin forms ion channels in both artificial and biological membranes. Accumulation of duramycin and coalescence of initially small channels into larger ones is considered to be responsible for the recorded behaviour and to final disruption of membranes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1377492     DOI: 10.1016/0005-2736(92)90345-m

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Cystic fibrosis transmembrane conductance regulator dysfunction and its treatment.

Authors:  Jeremy Hull
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

Review 2.  Development of synthetic membrane transporters for anions.

Authors:  Anthony P Davis; David N Sheppard; Bradley D Smith
Journal:  Chem Soc Rev       Date:  2006-10-23       Impact factor: 54.564

3.  Activation of ion channels by lysylbradykinin in the HCA-7 colony 29 human adenocarcinoma cell line.

Authors:  R M Henderson; A W Cuthbert
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

Review 4.  New horizons in the treatment of cystic fibrosis.

Authors:  A W Cuthbert
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

5.  Chloride transporting capability of Calu-3 epithelia following persistent knockdown of the cystic fibrosis transmembrane conductance regulator, CFTR.

Authors:  L J MacVinish; G Cope; A Ropenga; A W Cuthbert
Journal:  Br J Pharmacol       Date:  2007-03-05       Impact factor: 8.739

6.  Increased exposure of phosphatidylethanolamine on the surface of tumor vascular endothelium.

Authors:  Jason H Stafford; Philip E Thorpe
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

7.  Curvature-dependent recognition of ethanolamine phospholipids by duramycin and cinnamycin.

Authors:  Kunihiko Iwamoto; Tomohiro Hayakawa; Motohide Murate; Asami Makino; Kazuki Ito; Tetsuro Fujisawa; Toshihide Kobayashi
Journal:  Biophys J       Date:  2007-05-04       Impact factor: 4.033

8.  Effects of duramycin on cardiac voltage-gated ion channels.

Authors:  Eva Zebedin; Xaver Koenig; Miroslav Radenkovic; Halyna Pankevych; Hannes Todt; Michael Freissmuth; Karlheinz Hilber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-01-05       Impact factor: 3.000

9.  Structure-activity relationships in cholapod anion carriers: enhanced transmembrane chloride transport through substituent tuning.

Authors:  Beth A McNally; Atanas V Koulov; Timothy N Lambert; Bradley D Smith; Jean-Baptiste Joos; Adam L Sisson; John P Clare; Valentina Sgarlata; Luke W Judd; Germinal Magro; Anthony P Davis
Journal:  Chemistry       Date:  2008       Impact factor: 5.236

Review 10.  Therapeutic Application of Lantibiotics and Other Lanthipeptides: Old and New Findings.

Authors:  Anton Du Preez van Staden; Winschau F van Zyl; Marla Trindade; Leon M T Dicks; Carine Smith
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.